Shield Therapeutics plc total revenue, net income and dynamics of changes in today
Net revenue Shield Therapeutics plc is now 734 000 GBp. Information about net revenue is taken from open sources. The dynamics of Shield Therapeutics plc net revenue has changed by 0 GBp over the last period. Net income Shield Therapeutics plc - -2 877 000 GBp. Information about net income is used from open sources. Shield Therapeutics plc online financial report chart. The financial report chart on our website displays information by dates from 30/09/2018 to 31/12/2020. The financial report on the chart of Shield Therapeutics plc allows you to clearly see the dynamics of fixed assets.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
0 GBp
-87.107 % ↓
0 GBp
-192.049 % ↓
30/09/2020
0 GBp
-87.107 % ↓
0 GBp
-192.049 % ↓
30/06/2020
0 GBp
+241.07 % ↑
0 GBp
-
31/03/2020
0 GBp
+241.07 % ↑
0 GBp
-
30/06/2019
0 GBp
-
0 GBp
-
31/03/2019
0 GBp
-
0 GBp
-
31/12/2018
0 GBp
-
0 GBp
-
30/09/2018
0 GBp
-
0 GBp
-
Show:
to
Shield Therapeutics plc financial report charts
Dates of Shield Therapeutics plc finance reports: 30/09/2018, 30/09/2020, 31/12/2020. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Shield Therapeutics plc is available online for such a date - 31/12/2020. Gross profit Shield Therapeutics plc is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Shield Therapeutics plc is 562 500 GBp
Shield Therapeutics plc quarterly report dates
Cost of revenue Shield Therapeutics plc is the total cost of producing and distributing of products and services of a company. Cost of revenue Shield Therapeutics plc is 171 500 GBp Total revenue Shield Therapeutics plc refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Shield Therapeutics plc is 734 000 GBp Operating income Shield Therapeutics plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Shield Therapeutics plc is -2 273 500 GBp
Net income Shield Therapeutics plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Shield Therapeutics plc is -2 877 000 GBp Current assets Shield Therapeutics plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Shield Therapeutics plc is 5 230 000 GBp Total assets Shield Therapeutics plc refers to the total amount of assets owned by a person or entity. Total assets Shield Therapeutics plc is 32 528 000 GBp
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
0 GBp
0 GBp
0 GBp
0 GBp
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
0 GBp
0 GBp
0 GBp
0 GBp
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
0 GBp
0 GBp
0 GBp
0 GBp
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
5.12 %
5.12 %
6.80 %
6.80 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
0 GBp
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
0 GBp
0 GBp
0 GBp
0 GBp
Last revenue report of Shield Therapeutics plc was 31/12/2020. According to last financial report total revenue in Shield Therapeutics plc was 0 and changed by -87.107% since last year. Net income in Shield Therapeutics plc was 0 GBp in last quartal, net income changes to -192.049%.
Current cash Shield Therapeutics plc - the sum of all of the cash a company has on the date of report. Current cash Shield Therapeutics plc is 2 940 000 GBp
